Subsequent in vivo and in vitro experiments confirmed that the transmembrane protein 164 (TMEM164) gene might be mainly involved in the positive regulation of IMF deposition and have a certain negative regulatory effect on AF deposition. The gene discussed is TMEM164; the disease is atrial fibrillation.